The private sector bank made provisions for bad loans and contingencies of Rs 25.38 crore for the September quarter
Revenue from operations fell 13.2% to Rs 1.32 trillion
The consolidated revenue from operations during the quarter increased 4 per cent to Rs 1,834 crore, driven by improvements in both branded and non-branded business.
The Kolkata-based bank had reported a net loss of Rs 883 crore in the same quarter last year
Despite higher spending on advertising, high competition in toothpastes could restrict meaningful recovery in lost market share and weigh on earnings
The Kolkata-headquartered bank had posted a net loss of Rs 883.17 crore in the July-September period of 2018-19
The Tata group company said its revenue from operations was driven by improvement in branded and non-branded business both in India and globally
Total income during the July-September quarter of the current fiscal dipped marginally to Rs 1,800.45 crore
Total income up 11% to Rs 1,332 cr; exports grow by 39%
The company has so far incurred Rs 1,430 crore for the capacity expansion programme
From Narendra Modi's inauguration of lobal Renewable Energy to Saurav Ganguly, Dravid meeting, Business Standard brings you the top events of the day to keep an eye on
Integrated metal production was 2,10,000 tonnes for the quarter, almost flat from a year ago
The government is likely to order an SFIO probe on the financial irregularities at troubled mortgage firm DHFL soon
United Bank of India, IOC, Bank of India and Yes Bank are set to announce their second quarterly results this week
Retail loans grew by 22% YoY, while SME loan book grew by 29.9%
It had reported a net profit of Rs 1,204.62 crore for the July-September period a year ago
Net profit stood at Rs 3,012 crore, as against Rs 945 crore for Q2FY19
Jubilant FoodWorks saw its same-store sales growth (SSG) at nearly 5% in Q2
Drug firm Jubilant Life Sciences on Friday reported a 18.88 per cent rise in consolidated net profit at Rs 249.39 crore for the quarter ended September 30, 2019. The company said its board has also approved demerger of the Life Science Ingredients business. Jubilant Life had posted a net profit of Rs 209.77 crore in the corresponding July-September period of the previous fiscal, it said in a filing to the BSE. Consolidated total revenue from operations stood at Rs 2,265.93 crore for the quarter under consideration as against Rs 2,269.49 crore in the same period a year ago. "We witnessed steady performance in revenue and improvement in operating profits in Q2'FY20 both on a YoY basis and sequentially," Jubilant Life Sciences Chairman Shyam S Bhartia and Co-Chairman & MD Hari S Bhartia said. The board of the company has approved the recommendations of a committee constituted to consider the option of reorganising the businesses of the company. The board has given go-ahead to ...
Firm provides nearly Rs 25 crore on Essel group debentures in books